<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00873067</url>
  </required_header>
  <id_info>
    <org_study_id>HCP/08/207-4495-CFAE</org_study_id>
    <nct_id>NCT00873067</nct_id>
  </id_info>
  <brief_title>Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation</brief_title>
  <official_title>Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundacio Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate whether performing complex fractionated atrial
      electrograms ablation improves outcomes in persistent or atrial fibrillation ablation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from atrial arrhythmias without antiarrhythmic drugs</measure>
    <time_frame>1-year follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Freedom form atrial arrhythmias with or without antiarrhythmic drugs</measure>
    <time_frame>1-year follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of any complications in the acute phase or during follow-up</measure>
    <time_frame>1-year follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freedom from atypical atria flutter</measure>
    <time_frame>1-year follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in radioscopy time and radiofrequency application time</measure>
    <time_frame>1-year follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Catheter Ablation</condition>
  <arm_group>
    <arm_group_label>ACVP plus roof line</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard procedure for atrial fibrillation ablation, including pulmonary vein isolation plus roof line ablation. All ablation lines will be tested.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Additional CFAEs ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Atrial fibrillation ablation with pulmonary vein ablation and roof line. In addition, complex fractionated atrial electrograms ablation will be performed, lasting at most 30 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Additional Complex Fractionated Electrograms ablation</intervention_name>
    <description>Atrial fibrillation ablation with pulmonary vein ablation and roof line. In addition, complex fractionated atrial electrograms ablation will be performed, lasting at most 30 minutes.</description>
    <arm_group_label>Additional CFAEs ablation</arm_group_label>
    <other_name>Complex atrial fractionated electrograms ablation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard atrial fibrillation ablation procedure</intervention_name>
    <description>Standard procedure for persistent atrial fibrillation including circumferential pulmonary vein ablation and roof line, both being tested. No other lines or lesions will be performed.</description>
    <arm_group_label>ACVP plus roof line</arm_group_label>
    <other_name>ACVP ablation</other_name>
    <other_name>Roof line</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with persistent (more than 7 days, or less than 7 days needing pharmacologic
             or electric cardioversion)

          -  Presence of atrial fibrillation at the beginning of the procedure

        Exclusion Criteria:

          -  Hypo or hyperthyroidism

          -  Persistent long-lasting or non-defined duration atrial fibrillation

          -  Hypertrophic myocardiopathy

          -  Implantable defibrillation or pacemaker implanted

          -  Moderate or severe mitral valve disease or mitral prosthetic valve

          -  Ejection fraction less than 30%

          -  Left atrial anteroposterior diameter more than 50 mm.

          -  Previous atrial fibrillation ablation

          -  Contraindication to anticoagulation

          -  Left atrium thrombus

          -  Current infective disease or sepsis

          -  Pregnant women

          -  Current unstable angor

          -  Acute myocardial infarction in last 3 months

          -  Atrial fibrillation secondary to ionic disturbance, thyroids disease or secondary to
             any other reversible or non cardiovascular disease

          -  Reduced expectancy of life (less than 12 months)

          -  Patient participating in another clinical study that investigates a drug or device

          -  Psychologically unstable patient or denies to give informed consent

          -  Any cause that contraindicate ablation procedure or antiarrhythmic drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lluís Mont, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Clinic Universitary de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena Arbelo, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Clínic Universitari de Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Clinic Universitari de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2009</study_first_submitted>
  <study_first_submitted_qc>March 31, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2009</study_first_posted>
  <last_update_submitted>February 26, 2014</last_update_submitted>
  <last_update_submitted_qc>February 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Josep Lluis Mont Girbau</investigator_full_name>
    <investigator_title>Head of the Arrhythmia Unit</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Complex fractionated electrograms</keyword>
  <keyword>CFAE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

